ATE203913T1 - Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält - Google Patents
Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthältInfo
- Publication number
- ATE203913T1 ATE203913T1 AT94916430T AT94916430T ATE203913T1 AT E203913 T1 ATE203913 T1 AT E203913T1 AT 94916430 T AT94916430 T AT 94916430T AT 94916430 T AT94916430 T AT 94916430T AT E203913 T1 ATE203913 T1 AT E203913T1
- Authority
- AT
- Austria
- Prior art keywords
- cross
- growth factor
- linked gelatin
- fibroblasts
- gel preparation
- Prior art date
Links
- 239000000499 gel Substances 0.000 title abstract 4
- 108010010803 Gelatin Proteins 0.000 title abstract 2
- 239000008273 gelatin Substances 0.000 title abstract 2
- 229920000159 gelatin Polymers 0.000 title abstract 2
- 235000019322 gelatine Nutrition 0.000 title abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 title abstract 2
- 210000002950 fibroblast Anatomy 0.000 title 1
- 239000003102 growth factor Substances 0.000 title 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 abstract 4
- 238000001727 in vivo Methods 0.000 abstract 2
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002688 persistence Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15274993 | 1993-05-31 | ||
| PCT/JP1994/000876 WO1994027630A1 (en) | 1993-05-31 | 1994-05-31 | Cross-linked gelatin gel preparation containing basic fibroblast growth factor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE203913T1 true ATE203913T1 (de) | 2001-08-15 |
Family
ID=15547330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94916430T ATE203913T1 (de) | 1993-05-31 | 1994-05-31 | Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6831058B1 (de) |
| EP (1) | EP0702959B1 (de) |
| JP (1) | JP3639593B2 (de) |
| AT (1) | ATE203913T1 (de) |
| DE (1) | DE69427908T2 (de) |
| WO (1) | WO1994027630A1 (de) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8603511B2 (en) * | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
| US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
| US6063061A (en) * | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| JP2011046749A (ja) * | 1996-08-27 | 2011-03-10 | Baxter Internatl Inc | 癒着防止用の断片化重合体ヒドロゲルおよびそれらの調製 |
| US7435425B2 (en) | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
| AU736784B2 (en) * | 1997-06-03 | 2001-08-02 | Celltran Limited | New medicaments based on polymers composed of methacrylamide-modified gelatin |
| WO2001022989A2 (en) | 1999-09-30 | 2001-04-05 | Kaken Pharmaceutical Co., Ltd. | Method to enhance healing of sternum after sternotomy |
| WO2001030411A1 (fr) * | 1999-10-26 | 2001-05-03 | Kaken Pharmaceutical Co., Ltd. | Materiau de traitement d'embolie vasculaire a base d'hydrogel et therapie correspondante |
| WO2002019887A2 (en) * | 2000-09-05 | 2002-03-14 | Technion Research And Development Foundation Ltd. | Methods of repairing longitudinal bone defects |
| JP2003238439A (ja) * | 2002-02-13 | 2003-08-27 | Yasuhiko Tabata | 虚血治療剤 |
| KR100981443B1 (ko) * | 2002-04-01 | 2010-09-13 | 가켄 세야쿠 가부시키가이샤 | 염기성 선유 아세포 증식 인자 함유 치과용 점조 제제 |
| JP2004115413A (ja) * | 2002-09-25 | 2004-04-15 | Yasuhiko Tabata | 冠状動脈狭窄または閉塞治療用徐放性製剤 |
| JP2004123576A (ja) * | 2002-09-30 | 2004-04-22 | Medgel Corp | 多血小板血漿を含有する徐放性製剤 |
| US8834864B2 (en) | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
| JP4578067B2 (ja) * | 2003-06-06 | 2010-11-10 | 宏 清水 | 局所医薬組成物 |
| ES2339862T3 (es) * | 2003-06-20 | 2010-05-26 | Novartis Vaccines And Diagnostics, Inc. | Compuestos de piridino 1,2-a-pirimidin-4-ona como agentes anticancerosos. |
| US7927626B2 (en) | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| JP4532092B2 (ja) * | 2003-09-30 | 2010-08-25 | 泰彦 田畑 | 血管新生剤 |
| CA2542041C (en) * | 2003-10-10 | 2014-12-09 | Cellular Bioengineering, Inc. | Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants |
| JP2005218780A (ja) * | 2004-02-09 | 2005-08-18 | Menicon Co Ltd | 薬物放出速度を制御し得る薬物徐放可能なヒドロゲル材料の製造方法 |
| WO2005087257A1 (ja) * | 2004-03-16 | 2005-09-22 | Kaken Pharmaceutical Co., Ltd. | 架橋ゼラチンゲルを担体とする軟骨組織修復治療剤 |
| WO2005097166A1 (ja) * | 2004-04-09 | 2005-10-20 | Kaken Pharmaceutical Co., Ltd. | ゼラチンゲルを担体とする糖尿病性神経障害治療剤 |
| JP2005325075A (ja) * | 2004-05-14 | 2005-11-24 | Yasuhiko Tabata | 架橋ゼラチンゲルを担体とする半月板損傷治療剤 |
| US20080107703A1 (en) * | 2005-02-14 | 2008-05-08 | Yasuhiko Tabata | Hydrogel For Medical Use |
| TWI374750B (en) * | 2005-10-19 | 2012-10-21 | Univ Osaka | Therapeutic agent for use in regenerating dentin- dental pulp composite |
| US20070154546A1 (en) * | 2005-12-30 | 2007-07-05 | Zhang Jack Y | Sustained release pharmaceutical compositions |
| KR20090017654A (ko) | 2006-05-31 | 2009-02-18 | 백스터 인터내셔널 인코포레이티드 | 척수 수술에서 세포 내성장을 통제하고 조직 재생을 조절하는 방법 |
| EP2052740A4 (de) * | 2006-08-01 | 2009-11-11 | Nichiban Kk | Vernetzte mehrschichtige gelatinegelstruktur, träger für einen bioaktiven faktor, zubereitung zur freisetzung des bioaktiven faktors und herstellungsverfahren dafür |
| TWI436793B (zh) | 2006-08-02 | 2014-05-11 | 巴克斯特國際公司 | 快速作用之乾密封膠及其使用和製造方法 |
| WO2008047904A1 (fr) * | 2006-10-20 | 2008-04-24 | National University Corporation Nagoya University | Agent thérapeutique pour vasculopathie périphérique oblitérante et utilisation |
| WO2008072379A1 (ja) * | 2006-12-13 | 2008-06-19 | Fujifilm Corporation | 修飾された生体高分子の製造方法及び生体高分子の架橋方法 |
| JP5047603B2 (ja) * | 2006-12-15 | 2012-10-10 | エア・ウォーター株式会社 | ゼラチン成形物およびその製造方法 |
| EP1961411A1 (de) * | 2007-02-21 | 2008-08-27 | FUJIFILM Manufacturing Europe B.V. | Zusammensetzung mit gesteuerter Freisetzung |
| EP1961414A1 (de) * | 2007-02-21 | 2008-08-27 | FUJIFILM Manufacturing Europe B.V. | Rekombinante Gelatine enthaltende Zusammensetzung mit gesteuerter Freisetzung |
| WO2008103043A1 (en) * | 2007-02-21 | 2008-08-28 | Fujifilm Manufacturing Europe B.V. | Rgd containing recombinant gelatin |
| DE102007051059B4 (de) * | 2007-10-18 | 2014-04-03 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen |
| US8790698B2 (en) | 2007-10-30 | 2014-07-29 | Baxter International Inc. | Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects |
| ATE543507T1 (de) | 2007-11-07 | 2012-02-15 | Ono Pharmaceutical Co | Sdf-1 enthaltende zusammensetzung mit anhaltender freisetzung |
| CN102014973A (zh) | 2008-02-29 | 2011-04-13 | 弗罗桑医疗设备公司 | 用于促进止血和/或伤口愈合的装置 |
| WO2010089873A1 (ja) * | 2009-02-05 | 2010-08-12 | ニチバン株式会社 | 照射架橋水溶性高分子粒子及び照射架橋ゼラチン粒子並びにこれらの製造方法 |
| WO2010128672A1 (ja) * | 2009-05-07 | 2010-11-11 | 富士フイルム株式会社 | 遺伝子組み換えゼラチンを含む血管新生誘導剤 |
| US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
| US9162006B2 (en) | 2009-06-16 | 2015-10-20 | Baxter International Inc. | Hemostatic sponge |
| US8895508B2 (en) | 2009-07-24 | 2014-11-25 | Yasuhiki Tabata | Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particles |
| JP5514222B2 (ja) * | 2009-11-02 | 2014-06-04 | ニチバン株式会社 | 電離性放射線で架橋したヒドロゲルから成る生体内薬剤徐放用担体材料及びその製造方法 |
| US20120225483A1 (en) * | 2009-11-13 | 2012-09-06 | Hitachi-High-Technologies | Microsphere-Containing Cell Aggregate |
| WO2011079336A1 (en) | 2009-12-16 | 2011-07-07 | Baxter International Inc. | Hemostatic sponge |
| SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
| ES2682302T3 (es) | 2010-06-01 | 2018-09-19 | Baxter International Inc | Proceso para la producción de composiciones hemostáticas secas y estables |
| AU2011260260B2 (en) | 2010-06-01 | 2015-09-03 | Baxter Healthcare S.A. | Process for making dry and stable hemostatic compositions |
| MX344402B (es) | 2010-06-01 | 2016-12-14 | Baxter Int Inc * | Proceso para elaborar composiciones hemostaticas secas y estables. |
| ES2938568T3 (es) | 2011-10-11 | 2023-04-12 | Baxter Int | Composiciones hemostaticas |
| HK1201212A1 (en) | 2011-10-11 | 2015-08-28 | Baxter International Inc | Hemostatic compositions |
| SG11201401878SA (en) | 2011-10-27 | 2014-09-26 | Baxter Int | Hemostatic compositions |
| WO2013131520A2 (en) | 2012-03-06 | 2013-09-12 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
| RU2636240C2 (ru) | 2012-06-12 | 2017-11-21 | Ферросан Медикал Дивайсиз А/С | Сухая гемостатическая композиция |
| US9347037B2 (en) * | 2013-02-11 | 2016-05-24 | Evan Masataka Masutani | Methods and apparatus for building complex 3D scaffolds and biomimetic scaffolds built therefrom |
| EP2957287B1 (de) | 2013-02-15 | 2019-04-03 | KORTUC Inc. | Strahlungs-/chemotherapiesensibilisator zur lokalen intratumoralen injektion und zur kontrollierten freisetzung von wasserstoffperoxid mit hydrogel als träger |
| EP3010419B1 (de) | 2013-06-21 | 2020-05-20 | Ferrosan Medical Devices A/S | Vakuumerweiterte trockenzusammensetzung und spritze zum zurückhalten davon |
| JP6489485B2 (ja) | 2013-12-11 | 2019-03-27 | フェロサン メディカル デバイシーズ エイ/エス | 押し出し増強因子を含んでいる乾燥組成物 |
| CA2960309A1 (en) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
| RU2705905C2 (ru) | 2014-12-24 | 2019-11-12 | Ферросан Медикал Дивайсиз А/С | Шприц для удерживания и смешивания первого и второго веществ |
| AU2016290433B2 (en) | 2015-07-03 | 2018-05-24 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
| US11207258B2 (en) | 2016-01-25 | 2021-12-28 | Suntory Holdings Limited | Capsule containing functional substance and method for manufacturing said capsule |
| JP6820912B2 (ja) * | 2016-03-28 | 2021-01-27 | 富士フイルム株式会社 | 製剤、製剤用部材およびそれらの製造方法 |
| ES2968412T3 (es) | 2018-05-09 | 2024-05-09 | Ferrosan Medical Devices As | Método para preparar una composición hemostática |
| JP2023015416A (ja) * | 2019-12-27 | 2023-02-01 | Eaファーマ株式会社 | 瘻孔治療用材料 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3923969A (en) * | 1973-06-12 | 1975-12-02 | Battelle Institut E V | Carrier system for a drug with sustained release |
| US4785079A (en) * | 1984-11-09 | 1988-11-15 | The Salk Institute For Biological Studies | Isolation of fibroblast growth factor |
| IL74715A0 (en) * | 1984-03-27 | 1985-06-30 | Univ New Jersey Med | Biodegradable matrix and methods for producing same |
| JPH0759522B2 (ja) * | 1985-12-27 | 1995-06-28 | 住友製薬株式会社 | 徐放性製剤の製造法 |
| JP2587219B2 (ja) * | 1986-06-10 | 1997-03-05 | エーザイ株式会社 | 溶解遅延性のゼラチン製剤組成物 |
| NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
| US5164410A (en) * | 1988-01-09 | 1992-11-17 | Takeda Chemical Industries, Ltd. | Fumagillol derivatives and pharmaceutical compositions thereof |
| JPH01282394A (ja) | 1988-05-10 | 1989-11-14 | Toshiba Corp | 電動機の張力制御装置 |
| US4950483A (en) * | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
| JPH0249734A (ja) * | 1988-08-12 | 1990-02-20 | Wakunaga Pharmaceut Co Ltd | 新規組成物 |
| US5202311A (en) * | 1988-08-19 | 1993-04-13 | Children's Medical Center Corporation | Stabilized fgf composition |
| US5298243A (en) * | 1988-10-20 | 1994-03-29 | Denki Kagaku Kogyo Kabushiki Kaisha | Colony stimulating factor-gelatin conjugate |
| US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| CA2020654A1 (en) * | 1989-07-07 | 1991-01-08 | Yohko Akiyama | Stabilized fgf composition and production thereof |
| GB9014871D0 (en) * | 1990-07-05 | 1990-08-22 | Erba Carlo Spa | Drug delivery system for administering growth factor |
| JP3135138B2 (ja) * | 1990-12-19 | 2001-02-13 | 科研製薬株式会社 | 骨疾患治療剤 |
| JPH05132426A (ja) * | 1991-02-15 | 1993-05-28 | Takeda Chem Ind Ltd | 骨組織の形成促進剤 |
| US5270300A (en) * | 1991-09-06 | 1993-12-14 | Robert Francis Shaw | Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
| US5656598A (en) * | 1994-03-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Use of fibroblast growth factors to stimulate bone growth |
| EP0881908B1 (de) * | 1994-03-08 | 2004-06-16 | Osteosa Inc. | Verwendung von fibroblastwachstumsfaktoren zur stimulierung des knochenwachstums |
-
1994
- 1994-05-31 JP JP50048195A patent/JP3639593B2/ja not_active Expired - Lifetime
- 1994-05-31 WO PCT/JP1994/000876 patent/WO1994027630A1/ja not_active Ceased
- 1994-05-31 DE DE69427908T patent/DE69427908T2/de not_active Expired - Lifetime
- 1994-05-31 EP EP94916430A patent/EP0702959B1/de not_active Expired - Lifetime
- 1994-05-31 AT AT94916430T patent/ATE203913T1/de not_active IP Right Cessation
-
1995
- 1995-11-30 US US08/567,355 patent/US6831058B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69427908T2 (de) | 2001-11-22 |
| US6831058B1 (en) | 2004-12-14 |
| JP3639593B2 (ja) | 2005-04-20 |
| EP0702959A1 (de) | 1996-03-27 |
| DE69427908D1 (de) | 2001-09-13 |
| WO1994027630A1 (en) | 1994-12-08 |
| EP0702959B1 (de) | 2001-08-08 |
| EP0702959A4 (de) | 1996-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69427908D1 (de) | Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält | |
| DE69414626D1 (de) | Helle Haarpflegezusammensetzung | |
| CA2047154A1 (en) | Hair dye composition and its application method | |
| DE19775083I2 (de) | 7-Piperazinyl-oder 7-Morpholino-4-oxo-chinolin-3-carbonsaeurederivate ihre Herstellung und ihre Verwendung als antimikrobielle Mittel | |
| PT871476E (pt) | Composicao seca de factor sanguineo compreendendo trealose | |
| ATE89723T1 (de) | Retinoide zur behandlung lichtgeschaedigter haut. | |
| SE8603228L (sv) | Sarlekningsmedel | |
| ATE207761T1 (de) | Insulin formulierung | |
| DE3788840D1 (de) | Wasserabsorbierende Zusammensetzung mit verlängerter Lagerfähigkeit und welche die Faserbildung erleichtert. | |
| CA2006386A1 (en) | Absorbent material | |
| DE69115765D1 (de) | Herstellung von optisch aktiven arylaliphatischen Carbonsäuren | |
| IT8721063A0 (it) | Composizione ad attivita'tricogena. | |
| DE3889980D1 (de) | Reaktivfarbstoffe, deren Herstellung und Verwendung. | |
| DE68905705D1 (de) | Sphaerische phosphoraggregate, ihre herstellung und verwendung in roentgenstrahlschirmen. | |
| ATE90510T1 (de) | Antimikrobische zusammensetzung und deren verwendung. | |
| PT86153A (de) | Optisch aktive gyrasehemmer ihre herstellung und verwendung als antibiotika | |
| NO902104L (no) | Kosmetisk blanding. | |
| ATE45164T1 (de) | Steroido(3,2-c>-pyrazole, als antiandrogene und ihre herstellung. | |
| ITRM920384A1 (it) | Procedimento per la produzione di leuco coloranti allo zolfo e prodotto ottenuto. | |
| EP0409369A3 (en) | Substituted pyrimidinyloxy-(thio)-and triazinyloxy-(thio)acrylic acid derivatives, process for their preparation and their use as an agent with herbicidic, fungicidic and plantgrowth regulating activity | |
| DE3868287D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
| DE3872337D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
| DE3865049D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
| DE68912083D1 (de) | Substituierte Karbonsäuren, ihre Herstellung und Verwendung. | |
| DE3868104D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |